ACMR ACM Research, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ACMR Stock | Fundamental Analysis & Investment Insights
NASDAQ
Technology
Semiconductor Equipment & Materials
Current Price
Live
$66.59
Analyst Target
$51.87
-22.1%
Downside
52W High
$71.65
52W Low
$16.82
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 21, 2026
Market cap
$4.32B
P/E
38.72
ROE
9.9%
Profit margin
13.3%
Debt/Equity
0.16
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
ACMR exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability, though the absence of an Altman Z-Score raises concern about default risk. The stock trades at a premium to its Graham Number ($29.23) and intrinsic value ($47.39), reflecting high growth expectations despite recent earnings deterioration. Insider selling totaling $15.79M over six months signals bearish sentiment from leadership, and the most recent quarterly earnings missed estimates with a -6.78% average surprise. Analysts recommend 'buy' with a target of $51.87, implying a 22% downside from current levels, which is inconsistent with the stock’s elevated valuation and weakening momentum.
Key Strengths
Piotroski F-Score of 7/9 indicates strong financial health and operational efficiency
High gross margin (46.68%) and solid revenue growth (32.00% YoY)
Strong liquidity with current ratio of 3.48 and quick ratio of 2.44
Low debt/equity ratio (0.16) and no reported debt or cash figures suggest conservative capital structure
Historical track record of significant EPS surprises, including multiple quarters with over 100% beat rates
Key Risks
Recent earnings growth has turned negative (-42.9% YoY EPS growth), signaling a potential top in momentum
Insider selling of 321,250 shares ($15.79M value) in last 6 months indicates bearish sentiment from leadership
Current price ($66.59) is significantly above both Graham Number ($29.23) and intrinsic value ($47.39), implying high valuation premium
Analyst target price ($51.87) implies ~22% downside, suggesting market skepticism about near-term sustainability
Q/Q EPS growth is -18.2%, and last 4 quarters only 1 beat, with average surprise of -6.78%, indicating deteriorating earnings quality
AI Fair Value Estimate
Based on comprehensive analysis
$47.39
-28.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
48
Moderate
45
50
75
70
0
AI Verdict
neutral-to-bearish
Key drivers: Strong Piotroski F-Score and low leverage support financial health, High valuation relative to intrinsic value and Graham Number, Recent earnings deterioration and insider selling undermine growth narrative, Analyst target implies significant downside, Weakness in forward momentum despite strong past performance
Confidence
85%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- Graham Number of $29.23 provides a defensive floor
- Intrinsic value of $47.39 suggests undervaluation based on growth assumptions
Watchpoints
- Current price of $66.59 is 40.5% above intrinsic value
- P/E of 38.72 is below sector average (80.48), but still elevated for a company with slowing earnings growth
- No PEG ratio available, but implied growth deceleration reduces growth premium justification
Future
50/100
Ref Growth rates
Positives
- 32.00% YoY revenue growth indicates strong top-line momentum
- Historical ability to beat earnings estimates by large margins
Watchpoints
- Earnings growth has turned negative (-42.9% YoY)
- Q/Q EPS growth is -18.2%, signaling weakening profitability
- Last 4 quarters: only 1 beat, average surprise -6.78%
Past
75/100
Ref Historical trends
Positives
- Consistent history of significant EPS beats (e.g., +246.2%, +685.7%)
- Strong 5-year return (+78.4%) and 3-year return (+449.9%)
- High gross margin (46.68%) and improving operating margin trend
Watchpoints
- Recent earnings quality has declined sharply
- 2025 Q3 and Q4 saw large misses (-32.4%, -4.4%)
- 2026 Q1 estimate ($0.40) not yet reported, but trend is weakening
Health
70/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 7/9 indicates strong financial health
- Low debt/equity (0.16) and high liquidity (current ratio 3.48)
- No reported debt or cash figures, but ratios suggest conservative balance sheet
Watchpoints
- No Altman Z-Score available, which is a critical gap for distress risk assessment
- Absence of Z-Score prevents formal bankruptcy risk evaluation
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio
- Dividend Strength: 0/100
- Payout Ratio: 0.00%
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$66.59
Analyst Target
$51.87
Upside/Downside
-22.1%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACMR and closest competitors.
Updated 2026-02-20
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACMR
ACM Research, Inc.
Primary
|
+78.4% | +449.9% | +148.5% | +118.1% | +24.6% | +2.7% |
|
ACIW
ACI Worldwide, Inc.
Peer
|
-3.2% | +58.9% | -20.9% | -17.1% | -4.7% | +3.3% |
|
AVT
Avnet, Inc.
Peer
|
+47.0% | +23.1% | -3.7% | -3.7% | +3.3% | +0.0% |
|
BDC
Belden Inc.
Peer
|
+142.3% | +46.6% | -4.7% | -10.3% | -2.7% | -0.7% |
|
ENPH
Enphase Energy, Inc.
Peer
|
-82.6% | -86.1% | -44.9% | -11.6% | +10.7% | -0.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
38.72
Forward P/E
33.18
PEG Ratio
N/A
P/B Ratio
3.02
P/S Ratio
4.91
EV/Revenue
4.38
EV/EBITDA
26.85
Market Cap
$4.32B
Profitability
Profit margins and return metrics
Profit Margin
13.3%
Operating Margin
10.75%
Gross Margin
46.68%
ROE
9.94%
ROA
3.57%
Growth
Revenue and earnings growth rates
Revenue Growth
+32.0%
Earnings Growth
+13.7%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+16.1%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.16
Low debt
Current Ratio
3.48
Strong
Quick Ratio
2.44
Excellent
Cash/Share
$17.41
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-26
$N/A
2025-11-05
$0.36
-32.4% surprise
2025-08-06
$0.44
-4.4% surprise
2025-05-07
$0.3
+16.5% surprise
Technology Sector Comparison
Comparing ACMR against 149 companies in the Technology sector
(11 bullish, 67 neutral, 71 bearish)
P/E Ratio
38.72
This Stock
vs
80.58
Sector Avg
-52.0%
(Discount)
Return on Equity (ROE)
9.94%
This Stock
vs
-6.46%
Sector Avg
-253.7%
(Below Avg)
Profit Margin
13.3%
This Stock
vs
-9.26%
Sector Avg
-243.7%
(Weaker)
Debt to Equity
0.16
This Stock
vs
0.7
Sector Avg
-77.4%
(Less Debt)
Revenue Growth
32.0%
This Stock
vs
61.74%
Sector Avg
-48.2%
(Slower)
Current Ratio
3.48
This Stock
vs
3.39
Sector Avg
+2.6%
(Better)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACMR
ACM Research, Inc.
|
BEARISH | $4.32B | 38.72 | 9.9% | 13.3% | $66.59 | |
|
ACIW
ACI Worldwide, Inc.
|
NEUTRAL | $4.22B | 16.55 | 18.6% | 15.1% | $40.88 | |
|
AVT
Avnet, Inc.
|
NEUTRAL | $4.13B | 18.97 | 4.7% | 1.0% | $50.83 | |
|
BDC
Belden Inc.
|
NEUTRAL | $4.57B | 21.07 | 18.4% | 8.6% | $115.26 | |
|
ENPH
Enphase Energy, Inc.
|
BEARISH | $4.58B | 23.96 | 20.3% | 12.9% | $34.98 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-08 | MCKECHNIE MARK A | Chief Financial Officer | Sale | 31,250 | $1,091,507 |
| 2025-12-08 | MCKECHNIE MARK A | Chief Financial Officer | Option Exercise | 31,250 | $612,438 |
| 2025-12-04 | WANG DAVID HUI | Chief Executive Officer | Sale | 130,000 | $4,361,477 |
| 2025-12-04 | WANG DAVID HUI | Chief Executive Officer | Option Exercise | 130,000 | $130,000 |
| 2025-12-03 | CHEN FUPING | Officer | Sale | 120,000 | $3,981,156 |
| 2025-12-03 | CHEN FUPING | Officer | Option Exercise | 120,000 | $212,400 |
| 2025-11-13 | FENG LISA YI LU | Officer | Sale | 30,000 | $997,950 |
| 2025-11-13 | FENG LISA YI LU | Officer | Option Exercise | 30,000 | $168,000 |
| 2025-11-12 | DUN HAIPING | Director | Gift | 755,090 | - |
| 2025-09-18 | CHEAV SOTHEARA | Officer | Sale | 10,000 | $350,000 |
| 2025-09-18 | CHEAV SOTHEARA | Officer | Option Exercise | 10,000 | $138,900 |
| 2025-09-18 | WANG JIAN | Officer | Sale | 30,000 | $1,050,000 |
| 2025-09-18 | WANG JIAN | Officer | Option Exercise | 30,000 | $168,000 |
| 2025-09-17 | LIU TRACY DONG CPA | Director | Sale | 15,000 | $495,000 |
| 2025-09-17 | LIU TRACY DONG CPA | Director | Option Exercise | 15,000 | $15,000 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
6 analysts
Roth Capital
2025-09-30
Buy
Buy
Past News Coverage
Recent headlines mentioning ACMR from our newsroom.
Newest → oldest
No matching news yet.